{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:09:47Z","timestamp":1790514587904,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00228-018-2531-4","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T20:27:22Z","timestamp":1533760042000},"page":"1623-1631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Chronic hypnotic use at 10\u00a0years\u2014does the brand matter?"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-2277","authenticated-orcid":false,"given":"Yochai","family":"Schonmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Or","family":"Goren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Bareket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Comaneshter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Vinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJMcp1412740","volume":"373","author":"CG Solomon","year":"2015","unstructured":"Solomon CG, Winkelman JW (2015) Insomnia disorder. N Engl J Med 373:1437\u20131444. https:\/\/doi.org\/10.1056\/NEJMcp1412740","journal-title":"N Engl J Med"},{"key":"2531_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.12594","volume":"26","author":"D Riemann","year":"2017","unstructured":"Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gon\u00e7alves M, Hertenstein E, Jansson-Fr\u00f6jmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Wee\u00df HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K (2017) European guideline for the diagnosis and treatment of insomnia. J Sleep Res 26:675\u2013700. https:\/\/doi.org\/10.1111\/jsr.12594","journal-title":"J Sleep Res"},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M15-2175","volume":"165","author":"A Qaseem","year":"2016","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians (2016) Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians. Ann Intern Med 165:125\u2013133. https:\/\/doi.org\/10.7326\/M15-2175","journal-title":"Ann Intern Med"},{"key":"2531_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/15402002.2016.1220131","volume":"14","author":"MF Schmitz","year":"2016","unstructured":"Schmitz MF (2016) The ACP guidelines for treatment of chronic insomnia: the challenge of implementation. Behav Sleep Med 14:699\u2013700. https:\/\/doi.org\/10.1080\/15402002.2016.1220131","journal-title":"Behav Sleep Med"},{"key":"2531_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","volume":"1313","author":"MJ Sateia","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med J Clin Sleep Med J Clin Sleep Med 1313:307\u2013349. https:\/\/doi.org\/10.5664\/jcsm.6470","journal-title":"J Clin Sleep Med J Clin Sleep Med J Clin Sleep Med"},{"key":"2531_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5665\/sleep.3410","volume":"37","author":"SM Bertisch","year":"2014","unstructured":"Bertisch SM, Herzig SJ, Winkelman JW, Buettner C (2014) National use of prescription medications for insomnia: NHANES 1999-2010. Sleep 37:343\u2013349. https:\/\/doi.org\/10.5665\/sleep.3410","journal-title":"Sleep"},{"key":"2531_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.12688\/f1000research.8729.1","volume":"5","author":"Daniel F. Kripke","year":"2016","unstructured":"Kripke DF (2016) Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Research 5:918. doi: https:\/\/doi.org\/10.12688\/f1000research.8729.1","journal-title":"F1000Research"},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TAT Kurko","year":"2015","unstructured":"Kurko TAT, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies. Eur Psychiatry 30:1037\u20131047. https:\/\/doi.org\/10.1016\/j.eurpsy.2015.09.003","journal-title":"Eur Psychiatry"},{"key":"2531_CR9","first-page":"e398","volume":"56","author":"S Anthierens","year":"2010","unstructured":"Anthierens S, Pasteels I, Habraken H et al (2010) Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians\u2019 attitudes toward benzodiazepine prescribing. Can Fam physician M\u00e9decin Fam Can 56:e398\u2013e406","journal-title":"Can Fam physician M\u00e9decin Fam Can"},{"key":"2531_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2296-14-191","volume":"14","author":"C Sirdifield","year":"2013","unstructured":"Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN (2013) General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract 14:191. https:\/\/doi.org\/10.1186\/1471-2296-14-191","journal-title":"BMC Fam Pract"},{"key":"2531_CR11","doi-asserted-by":"publisher","unstructured":"Everitt H, Mcdermott L, Leydon G et al (2014) GPs\u2019 management strategies for patients with insomnia\u00a0: 112\u2013119. https:\/\/doi.org\/10.3399\/bjgp14X677176.Conclusion","DOI":"10.3399\/bjgp14X677176.Conclusion"},{"key":"2531_CR12","first-page":"616","volume":"60","author":"CM Campanelli","year":"2013","unstructured":"Campanelli CM (2013) American Geriatrics Society Updated Beers Criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc 60:616\u2013631","journal-title":"J Am Geriatr Soc"},{"key":"2531_CR13","unstructured":"Oecd (2015) Health at a glance 2015. OECD Publishing"},{"key":"2531_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/fampra\/7.4.258","volume":"7","author":"A Matalon","year":"1990","unstructured":"Matalon A, Yinnon AM, Hurwitz A (1990) Chronic use of hypnotics in a family practice--patients\u2019 reluctance to stop treatment. Fam Pract 7:258\u2013260","journal-title":"Fam Pract"},{"key":"2531_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2296-3-9","volume":"3","author":"L Mah","year":"2002","unstructured":"Mah L, Upshur REG (2002) Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract 3:9","journal-title":"BMC Fam Pract"},{"key":"2531_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11096-005-4731-0","volume":"27","author":"R Hulten van","year":"2005","unstructured":"van Hulten R, Teeuw B, Bakker A, Leufkens HG (2005) Initial benzodiazepine use and improved health-related quality of life. Pharm World Sci 27:41\u201346","journal-title":"Pharm World Sci"},{"key":"2531_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMra1611832","volume":"376","author":"M Soyka","year":"2017","unstructured":"Soyka M (2017) Treatment of benzodiazepine dependence. N Engl J Med 376:1147\u20131157. https:\/\/doi.org\/10.1056\/NEJMra1611832","journal-title":"N Engl J Med"},{"key":"2531_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8343","volume":"345","author":"TB Huedo-Medina","year":"2012","unstructured":"Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ 345:e8343. https:\/\/doi.org\/10.1136\/bmj.e8343","journal-title":"BMJ"},{"key":"2531_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","volume":"26","author":"AD Krystal","year":"2003","unstructured":"Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26:793\u2013799","journal-title":"Sleep"},{"key":"2531_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/sleep\/34.2.207","volume":"34","author":"TA Roehrs","year":"2011","unstructured":"Roehrs TA, Randall S, Harris E et al (2011) Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. Sleep 34:207\u2013212","journal-title":"Sleep"},{"key":"2531_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.sleep.2004.10.015","volume":"6","author":"S Ancoli-Israel","year":"2005","unstructured":"Ancoli-Israel S, Richardson GS, Mangano RM, Jenkins L, Hall P, Jones WS (2005) Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med 6:107\u2013113. https:\/\/doi.org\/10.1016\/j.sleep.2004.10.015","journal-title":"Sleep Med"},{"key":"2531_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.sleep.2005.06.004","volume":"6","author":"T Roth","year":"2005","unstructured":"Roth T, Walsh JK, Krystal A et al (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 6:487\u2013495. https:\/\/doi.org\/10.1016\/j.sleep.2005.06.004","journal-title":"Sleep Med"},{"key":"2531_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.5665\/sleep.2208","volume":"35","author":"S Randall","year":"2012","unstructured":"Randall S, Roehrs TA, Roth T (2012) Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep 35:1551\u20131557. https:\/\/doi.org\/10.5665\/sleep.2208","journal-title":"Sleep"},{"key":"2531_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/sleep\/31.1.79","volume":"31","author":"AD Krystal","year":"2008","unstructured":"Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group (2008) Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79\u201390","journal-title":"Sleep"},{"key":"2531_CR25","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.euroneuro.2010.10.005","volume":"21","author":"T Mattila","year":"2011","unstructured":"Mattila T, Stoyanova V, Elferink A, Gispen-de Wied C, de Boer A, Wohlfarth T (2011) Insomnia medication: do published studies reflect the complete picture of efficacy and safety? Eur Neuropsychopharmacol 21:500\u2013507. https:\/\/doi.org\/10.1016\/j.euroneuro.2010.10.005","journal-title":"Eur Neuropsychopharmacol"},{"key":"2531_CR26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/0269881110379307","volume":"24","author":"S Wilson","year":"2010","unstructured":"Wilson S, Nutt D, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG (2010) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 24:1577\u20131601. https:\/\/doi.org\/10.1177\/0269881110379307","journal-title":"J Psychopharmacol"},{"key":"2531_CR27","first-page":"29","volume":"96","author":"E Matheson","year":"2017","unstructured":"Matheson E, Hainer BL (2017) Insomnia: pharmacologic therapy. Am Fam Physician 96:29\u201335","journal-title":"Am Fam Physician"},{"key":"2531_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11920-016-0717-y","volume":"18","author":"S Creado","year":"2016","unstructured":"Creado S, Plante DT (2016) An update on the use of sedative-hypnotic medications in psychiatric disorders. Curr Psychiatry Rep 18:78. https:\/\/doi.org\/10.1007\/s11920-016-0717-y","journal-title":"Curr Psychiatry Rep"},{"key":"2531_CR29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.5665\/sleep.3914","volume":"37","author":"ES Ford","year":"2014","unstructured":"Ford ES, Wheaton AG, Cunningham TJ, Giles WH, Chapman DP, Croft JB (2014) Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care Survey 1999-2010. Sleep 37:1283\u20131293. https:\/\/doi.org\/10.5665\/sleep.3914","journal-title":"Sleep"},{"key":"2531_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.7326\/M15-1781","volume":"165","author":"TJ Wilt","year":"2016","unstructured":"Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL (2016) Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American college of physicians. Ann Intern Med 165:103\u2013112. https:\/\/doi.org\/10.7326\/M15-1781","journal-title":"Ann Intern Med"},{"key":"2531_CR31","unstructured":"OECD (2012) OECD reviews of health care quality: Israel 2012. OECD Publishing"},{"key":"2531_CR32","unstructured":"The Israel Drug Registry. http:\/\/www.old.health.gov.il\/units\/pharmacy\/trufot\/index.asp?safa=e . Accessed 13 Apr 2016"},{"key":"2531_CR33","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA (2003) Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 158:915\u2013920. https:\/\/doi.org\/10.1093\/aje\/kwg231","journal-title":"Am J Epidemiol"},{"key":"2531_CR34","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2016) Guidelines for ATC classification and DDD assignment 2016. Oslo. . Oslo"},{"key":"2531_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s001270200006","volume":"37","author":"SM Zandstra","year":"2002","unstructured":"Zandstra SM, Furer JW, van de Lisdonk EH, van\u2019t Hof M, Bor JHJ, van Weel C, Zitman FG (2002) Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 37:139\u2013144. https:\/\/doi.org\/10.1007\/s001270200006","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2531_CR36","unstructured":"Manor O (2015) Program for quality indicators in community healthcare in Israel Report 2013-2014"},{"key":"2531_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000434755","volume":"84","author":"J-M Cloos","year":"2015","unstructured":"Cloos J-M, Bocquet V, Rolland-Portal I, Koch P, Chouinard G (2015) Hypnotics and triazolobenzodiazepines \u2013 best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry. Psychother Psychosom 84:273\u2013283. https:\/\/doi.org\/10.1159\/000434755","journal-title":"Psychother Psychosom"},{"key":"2531_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003296","volume":"3","author":"IF Tvete","year":"2013","unstructured":"Tvete IF, Bj\u00f8rner T, Aursnes IA, Skomedal T (2013) A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing. BMJ Open 3:e003296. https:\/\/doi.org\/10.1136\/bmjopen-2013-003296","journal-title":"BMJ Open"},{"key":"2531_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ije\/dyw040","volume":"45","author":"S Greenland","year":"2016","unstructured":"Greenland S, Daniel R, Pearce N (2016) Outcome modelling strategies in epidemiology: traditional methods and basic alternatives. Int J Epidemiol 45:565\u2013575. https:\/\/doi.org\/10.1093\/ije\/dyw040","journal-title":"Int J Epidemiol"},{"key":"2531_CR40","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/aje\/kwg074","volume":"157","author":"LA McNutt","year":"2003","unstructured":"McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940\u2013943. https:\/\/doi.org\/10.1093\/aje\/kwg074","journal-title":"Am J Epidemiol"},{"key":"2531_CR41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/1536867X1301300304","volume":"13","author":"EC Norton","year":"2013","unstructured":"Norton EC, Miller MM, Kleinman LC (2013) Computing adjusted risk ratios and risk differences in Stata. Stata J 13:492\u2013509","journal-title":"Stata J"},{"key":"2531_CR42","unstructured":"Cohen R, Rabin H (2015) Membership in sick funds 2014 [Hebrew]. Jerusalem"},{"key":"2531_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.psychres.2016.01.040","volume":"237","author":"N Takeshima","year":"2016","unstructured":"Takeshima N, Ogawa Y, Hayasaka Y, Furukawa TA (2016) Continuation and discontinuation of benzodiazepine prescriptions: a cohort study based on a large claims database in Japan. Psychiatry Res 237:201\u2013207. https:\/\/doi.org\/10.1016\/j.psychres.2016.01.040","journal-title":"Psychiatry Res"},{"key":"2531_CR44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/fampra\/cmt010","volume":"30","author":"IAT Willems","year":"2013","unstructured":"Willems IAT, Gorgels WJMJ, Oude Voshaar RC, Mulder J, Lucassen PLBJ (2013) Tolerance to benzodiazepines among long-term users in primary care. Fam Pract 30:404\u2013410. https:\/\/doi.org\/10.1093\/fampra\/cmt010","journal-title":"Fam Pract"},{"key":"2531_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1176\/appi.ps.54.7.1006","volume":"54","author":"SB Soumerai","year":"2003","unstructured":"Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D (2003) Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Serv 54:1006\u20131011. https:\/\/doi.org\/10.1176\/appi.ps.54.7.1006","journal-title":"Psychiatr Serv"},{"key":"2531_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1176\/appi.ajgp.11.5.568","volume":"11","author":"SL Gray","year":"2003","unstructured":"Gray SL, Eggen AE, Blough D et al (2003) Benzodiazepine use in older adults enrolled in a health maintenance organization. Am J Geriatr Psychiatry 11:568\u2013576. https:\/\/doi.org\/10.1176\/appi.ajgp.11.5.568","journal-title":"Am J Geriatr Psychiatry"},{"key":"2531_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/138920008786049258","volume":"9","author":"R Mandrioli","year":"2008","unstructured":"Mandrioli R, Mercolini L, Raggi M (2008) Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab 9:827\u2013844. https:\/\/doi.org\/10.2174\/138920008786049258","journal-title":"Curr Drug Metab"},{"key":"2531_CR48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","volume":"4","author":"S Schutte-Rodin","year":"2008","unstructured":"Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4:487\u2013504","journal-title":"J Clin Sleep Med"},{"key":"2531_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1176\/ajp.148.2.151","volume":"148","author":"C Salzman","year":"1991","unstructured":"Salzman C (1991) The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. Am J Psychiatry 148:151\u2013152. https:\/\/doi.org\/10.1176\/ajp.148.2.151","journal-title":"Am J Psychiatry"},{"key":"2531_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00213-002-1376-8","volume":"167","author":"C Cuevas de las","year":"2003","unstructured":"de las Cuevas C, Sanz E, de la Fuente J (2003) Benzodiazepines: more \u201cbehavioural\u201d addiction than dependence. Psychopharmacology 167:297\u2013303. https:\/\/doi.org\/10.1007\/s00213-002-1376-8","journal-title":"Psychopharmacology"},{"key":"2531_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00228-011-1124-2","volume":"68","author":"SR Kjosavik","year":"2012","unstructured":"Kjosavik SR, Ruths S, Hunskaar S (2012) Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway. Eur J Clin Pharmacol 68:311\u2013319. https:\/\/doi.org\/10.1007\/s00228-011-1124-2","journal-title":"Eur J Clin Pharmacol"},{"key":"2531_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/appy.12147","volume":"7","author":"CF Yen","year":"2015","unstructured":"Yen CF, Ko CH, Chang YP, Yu CY, Huang MF, Yeh YC, Lin JJ, Chen CS (2015) Dependence, misuse, and beliefs regarding use of hypnotics by elderly psychiatric patients taking zolpidem, estazolam, or flunitrazepam. Asia Pac Psychiatry 7:298\u2013305. https:\/\/doi.org\/10.1111\/appy.12147","journal-title":"Asia Pac Psychiatry"},{"key":"2531_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","volume":"104","author":"SY Fang","year":"2009","unstructured":"Fang SY, Chen CY, Chang IS, Wu ECH, Chang CM, Lin KM (2009) Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug Alcohol Depend 104:140\u2013146. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.04.017","journal-title":"Drug Alcohol Depend"},{"key":"2531_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10488-011-0381-9","volume":"40","author":"L Ayalon","year":"2013","unstructured":"Ayalon L, Gross R, Yaari A, Feldhamer E, Balicer RD, Goldfracht M (2013) Patients\u2019 and physicians\u2019 characteristics associated with the purchase of benzodiazepines by older primary care patients in Israel. Admin Pol Ment Health 40:117\u2013123. https:\/\/doi.org\/10.1007\/s10488-011-0381-9","journal-title":"Admin Pol Ment Health"},{"key":"2531_CR55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/YIC.0000000000000080","volume":"30","author":"H Taipale","year":"2015","unstructured":"Taipale H, Koponen M, Tanskanen A et al (2015) Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer\u2019s disease. Int Clin Psychopharmacol 30:202\u2013208. https:\/\/doi.org\/10.1097\/YIC.0000000000000080","journal-title":"Int Clin Psychopharmacol"},{"key":"2531_CR56","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00228-007-0349-6","volume":"63","author":"J Haukka","year":"2007","unstructured":"Haukka J, Suvisaari J, Tuulio-Henriksson A, L\u00f6nnqvist J (2007) High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 63:1069\u20131074. https:\/\/doi.org\/10.1007\/s00228-007-0349-6","journal-title":"Eur J Clin Pharmacol"},{"key":"2531_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AJP.0000000000000248","volume":"32","author":"A Lacasse","year":"2015","unstructured":"Lacasse A, Ware MA, Bourgault P et al (2015) Accuracy of self-reported prescribed analgesic medication use. Clin J Pain 32:1\u2013102. https:\/\/doi.org\/10.1097\/AJP.0000000000000248","journal-title":"Clin J Pain"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2531-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2531-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2531-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T13:00:15Z","timestamp":1604754015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2531-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2531-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"9 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the CHS institutional ethics review board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}